Literature DB >> 24426244

Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.

Hardik Dodiya1, Amit Patel1, Dipal Patel1, Ashish Kaushal1, D G Vijay1.   

Abstract

The objective of study was to evaluate and correlate the pathological characteristics of breast cancer patients with estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2/neu) detected by immunohistochemistry and/or fluorescent in situ hybridization method. We have conducted 2 year study of 204 cases of breast cancer at HCG-Medisurge Hospitals, Ahmedabad from 2009 to 2011. Significant correlation was found in ER and PR expression whereas no correlation was found in hormonal receptors and Her2/neu expression. ER and PR positivity increased with advancing age in breast carcinoma patients while not affecting Her2/neu expression. The expression of hormone receptors were higher in infiltrating lobular carcinoma and infiltrating duct carcinoma subtypes of breast carcinoma as compared to other subtypes such medullary and in situ carcinoma. High-grade carcinoma patients were predominantly ER/PR negative and Her2/neu positive as compared to lower grade breast carcinoma whereas high-stage carcinoma patients were ER/PR positive and Her2/neu positive as compared to lower stage breast carcinoma.

Entities:  

Keywords:  Estrogen receptors; Human epidermal growth factor receptors; Progesterone receptors

Year:  2013        PMID: 24426244      PMCID: PMC3783920          DOI: 10.1007/s12291-012-0294-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  35 in total

1.  HER2 status and benefit from adjuvant trastuzumab in breast cancer.

Authors:  Soonmyung Paik; Chungyeul Kim; Norman Wolmark
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

2.  Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.

Authors:  K Horita; A Yamaguchi; K Hirose; M Ishida; S Noriki; Y Imamura; M Fukuda
Journal:  Eur J Histochem       Date:  2001       Impact factor: 3.188

3.  Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.

Authors:  Moses Ambroise; Mitra Ghosh; V S Mallikarjuna; Ann Kurian
Journal:  Asian Pac J Cancer Prev       Date:  2011

4.  Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.

Authors:  Victor R Grann; Andrea B Troxel; Naseem J Zojwalla; Judith S Jacobson; Dawn Hershman; Alfred I Neugut
Journal:  Cancer       Date:  2005-06-01       Impact factor: 6.860

5.  HER2/neu amplification in breast cancer: stratification by tumor type and grade.

Authors:  Elise R Hoff; Raymond R Tubbs; Jonathan L Myles; Gary W Procop
Journal:  Am J Clin Pathol       Date:  2002-06       Impact factor: 2.493

6.  Hormone receptor expression and Her/2neu amplification in breast carcinoma in a cohort of Sri Lankans.

Authors:  N Ratnatunga; L V C Liyanapathirana
Journal:  Ceylon Med J       Date:  2007-12

7.  Do we need HER-2/neu testing for all patients with primary breast carcinoma?

Authors:  Susanne Taucher; Margaretha Rudas; Robert M Mader; Michael Gnant; Peter Dubsky; Thomas Bachleitner; Sebastian Roka; Florian Fitzal; Daniela Kandioler; Emanuel Sporn; Josef Friedl; Martina Mittlböck; Raimund Jakesz
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

8.  Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer.

Authors:  S Thoresen; T Thorsen; M Tangen; F Hartveit
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

9.  Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is?

Authors:  Tanuja Shet; Atin Agrawal; Mandar Nadkarni; Mahendra Palkar; Rohini Havaldar; Vani Parmar; Rajendra Badwe; R F Chinoy
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

10.  Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.

Authors:  Hirotaka Iwase; Junichi Kurebayashi; Hitoshi Tsuda; Tomohiko Ohta; Masafumi Kurosumi; Kazuaki Miyamoto; Yutaka Yamamoto; Takuji Iwase
Journal:  Breast Cancer       Date:  2009-05-23       Impact factor: 4.239

View more
  2 in total

1.  Clinicopathological characteristics of breast cancer patients from Northern Tanzania: common aspects of late stage presentation and triple negative breast cancer.

Authors:  Marianne Gnanamuttupulle; Oliver Henke; Shilanaiman Hilary Ntundu; Furaha Serventi; Leila E Mwakipunda; Patrick Amsi; Alex Mremi; Kondo Chilonga; David Msuya; Samuel G Chugulu
Journal:  Ecancermedicalscience       Date:  2021-09-07

2.  Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use.

Authors:  Prem Chand; Anubha Garg; Vandana Singla; Nisha Rani
Journal:  Niger J Surg       Date:  2018 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.